Evidence map›Paper›PMID 40074858›Full record

ArticleNPJ digital medicine2025

AI in Histopathology Explorer for comprehensive analysis of the evolving AI landscape in histopathology.

Yingrui Ma, Shivprasad Jamdade, Lakshmi Konduri, Heba Sailem

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Artificial intelligence-based quantification of epidermal proliferation and apoptosis in human skin.JID innovations : skin science from molecules to population health · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yingrui MaSchool of Cancer and Pharmaceutical Sciences, Stamford St., Franklin Wilkins Building, King's College London, London, UK.
Shivprasad JamdadeSchool of Cancer and Pharmaceutical Sciences, Stamford St., Franklin Wilkins Building, King's College London, London, UK.
Lakshmi KonduriSchool of Cancer and Pharmaceutical Sciences, Stamford St., Franklin Wilkins Building, King's College London, London, UK.
Heba SailemSchool of Cancer and Pharmaceutical Sciences, Stamford St., Franklin Wilkins Building, King's College London, London, UK. heba.sailem@kcl.ac.uk.ORCID http://orcid.org/0000-0002-6600-1255

Funding

Wellcome TrustWellcome Trust (Wellcome) 225974/Z/22/Z
6 · The paper itself

Abstract

Digital pathology and artificial intelligence (AI) hold immense transformative potential to revolutionize cancer diagnostics, treatment outcomes, and biomarker discovery. Gaining a deeper understanding of deep learning algorithm methods applied to histopathological data and evaluating their performance on different tasks is crucial for developing the next generation of AI technologies. To this end, we developed AI in Histopathology Explorer (HistoPathExplorer); an interactive dashboard with intelligent tools available at www.histopathexpo.ai . This real-time online resource enables users, including researchers, decision-makers, and various stakeholders, to assess the current landscape of AI applications for specific clinical tasks, analyze their performance, and explore the factors influencing their translation into practice. Moreover, a quality index was defined for evaluating the comprehensiveness of methodological details in published AI methods. HistoPathExplorer highlights opportunities and challenges for AI in histopathology, and offers a valuable resource for creating more effective methods and shaping strategies and guidelines for translating digital pathology applications into clinical practice.

Identifiers

PMID40074858
PMCPMC11904230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.